• Biodegradable, not metal – fast reabsorbable • Inserted directly into tumors with existing procedures and equipment • With 2.7-day half-life, shorter therapy-to-complete-decay • Show promise for use for brain, head and neck tumors and liver cancer, in addition to prostate cancer
• Injectable polymer is thermally reversible – goes from liquid to solid lattice that holds Yttrium-90 microspheres in place • For precise placement in tumors that cannot be removed by surgery or in periphery where seed placement not practical
There is value in the diversity of the company's approach. Every aspect of their business holds great promise and use. Whether it be their polymer seed tech, radiogel, or perhaps the most imminently important, proposed isotope production, the prospective value of the company is quite real.